Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
959 participants
INTERVENTIONAL
2003-06-30
2007-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevention of Iron Deficiency Anemia Post-delivery
NCT05590260
Fermented Iron-rich Supplement in Reducing Anemia
NCT02037724
Iron Absorption and Requirements in Pregnancy and Lactation
NCT05973552
Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania
NCT06079918
Iron Deficiency Anemia Among Chinese Pregnant Women: a Multi-center Prospective Cohort Study
NCT03961074
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Comparisons: Clinics will be randomized to one of three strategies: 1)Selective anemia screening and treatment of anemic women, 2)universal anemia screening and treatment of anemic women, or 3)universal iron supplementation of 65 mg a day for three months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Daily iron supplements of 65 mg a day for 3 months
Universal anemia screening and treatment
Selective anemia screening and treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 13 years or more
* WIC certified
Exclusion Criteria
* Hemoglobin \< 7 g/dL
13 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centers for Disease Control and Prevention
FED
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amal K Mitra, MD, DrPH
Role: PRINCIPAL_INVESTIGATOR
University of Southern Mississippi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center for Community Health, University of Southern Mississippi
Hattiesburg, Mississippi, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CDC-NCCDPHP-TS-0780
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.